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Abstract 
The aim of this study was to examine the antimicrobial susceptibility of 97 Haemophilus parasuis cultured from Australian pigs. As there 
is no existing standard antimicrobial susceptibility technique available for H. parasuis, methods utilising the supplemented media, BA/SN for 
disc diffusion and test medium broth (TMB) for a microdilution technique, were initially evaluated with the reference strains recommended by 
the Clinical and Laboratory Standards Institute. The results of the media evaluation suggested that BA/SN and TMB can be used as suitable 
media for susceptibility testing of H. parasuis. The proposed microdilution technique was then used with 97 H. parasuis isolates and nine 
antimicrobial agents. The study found that Australian isolates showed elevated minimum inhibitory concentrations (MICs) for ampicillin (1%), 
penicillin (2%), erythromycin (7%), tulathromycin (9%), tilmicosin (22%), tetracycline (31%) and trimethoprim-sulfamethoxazole (40%). This 
study has described potential antimicrobial susceptibility methods for H. parasuis and has detected a low percentage of Australian H. parasuis 
isolates with elevated antimicrobial MICs. 
 
Keywords: Haemophilus parasuis; Glässer’s disease; Antimicrobial susceptibility testing; Test medium broth (TMB); BA/SN 
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1. Introduction 
Haemophilus parasuis is a commensal of the upper respiratory tract of pigs but is also the causative agent of Glässer’s disease, which is 
characterised by polyserositis, polyarthritis and meningitis (Aragon et al., 2012; Jackson and Cockcroft, 2007). Glässer’s disease is a significant 
challenge to the pig industry as it can cause economic losses in pig production (Aragon et al., 2012). 
Antimicrobial agents such as beta-lactams, phenicols, macrolides, potentiated sulphonamides and tetracyclines, are recommended to 
control and treat H. parasuis infections (Karriker et al., 2013). Similar to other bacterial pathogens of pigs, the antimicrobial susceptibility of 
H. parasuis has evolved, thus, regular testing of susceptibility patterns is essential to ensure antimicrobials remain effective (Aarestrup et al., 
2008). Antimicrobial resistance has been detected in H. parasuis isolated from China (Zhou et al., 2010), the Czech Republic (Nedbalcová and 
Kucerova et al., 2013), Denmark (Aarestrup et al., 2004), the United Kingdom and Spain (de la Fuente et al., 2007). While resistance has already 
been identified in other countries, current knowledge on the antimicrobial resistance of H. parasuis is unavailable in Australia. Thus, this study 
intended to determine the antimicrobial susceptibility of H. parasuis cultured from Australian pigs. 
Additionally, this study was designed to perform preliminary evaluation of potential methods, using supplemented media, for the 
antimicrobial susceptibility testing of H. parasuis as no agreed standard method exists for this species. Haemophilus parasuis is a fastidious 
organism which does not grow in standard media recommended for other bacterial species as it requires V-factor (nicotinamide adenine 
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dinucleotide or NAD) for growth in vitro (Rapp-Gabrielson et al., 2006). The veterinary fastidious medium (VFM) and chocolate Mueller-
Hinton agar recommended by the Clinical and Laboratory Standards Institute (CLSI, 2013) for other fastidious bacteria have not proven suitable 
for use with Australian isolates of H. parasuis. 
2. Materials and Methods 
Escherichia coli (ATCC 25922) and Staphylococcus aureus (ATCC 25923 and ATCC 29213) and are the formal quality control strains 
when using the recommended media (Mueller-Hinton agar and broth) as defined by the CLSI (2013). These strains were used in the disc 
diffusion and microdilution techniques to test the capacity of BA/SN and TMB to function as media in antimicrobial susceptibility testing. The 
agar (BA/SN) was tested for disc diffusion, while the broth (TMB) was tested in the microdilution technique. Both BA/SN and TMB were used 
as they have a known capacity to support the growth of Australian H. parasuis. These media have been routinely used in the isolation and/or 
growth of haemophilic bacteria in the Microbiology Research Group, EcoSciences Precinct, Department of Agriculture, Fisheries and Forestry 
(DAFF), Queensland, Australia, for many years.  
BA/SN was made of blood agar based medium, BBLTM Blood Agar Base (BD), supplemented with 0.0025% of NADH, 0.0005% of thiamine 
HCl, 1% of heat inactivated horse serum and 5% of oleic acid bovine albumin complex which consists of 4.75% bovine serum albumin in 
normal saline (with the normal saline containing 0.06% oleic acid and 5% 0.05N NaOH) (Sigma-Aldrich). TMB was prepared with 1% Biosate 
Peptone (BD), 1% sodium chloride (Merck Millipore, Australia), 0.1% starch (Merck Millipore), 0.1% glucose (Univar, Ajax Finechem), 0.05% 
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yeast extract (Sigma-Aldrich) and was supplemented as for BA/SN except that 1% heat inactivated chicken serum was used in place of the horse 
serum. 
The antimicrobial susceptibility testing using the proposed media (BA/SN and TMB) and standard media was done by conducting disc 
diffusion and broth microdilution techniques on the reference strains, E. coli (ATCC 25922) and S. aureus (ATCC 25923 and ATCC 29213), in 
accordance with the CLSI standard (CLSI, 2013). The reference strains were subjected to a panel of antimicrobials (five for E. coli and nine for 
S. aureus), using the test media (BA/SN and TMB) and standard media (Mueller Hinton agar and broth) in six independent repeats to determine 
repeatability. The antimicrobials used for disc diffusion were: ampicillin (10 µg), ceftiofur (30 µg), erythromycin (15 µg), florfenicol (30 µg), 
penicillin (10 µg), tetracycline (30 µg), trimethoprim-sulfamethoxazole combination (SXT) (30 µg), tilmicosin (15 µg) (all from Oxoid) and 
tulathromycin (30 µg) (Pfizer, Animal Health, USA). The same antimicrobials were used for microdilution, all sourced from Sigma Aldrich 
except for ceftiofur and tulathromycin (Pfizer). For microdilution, stock solutions were prepared according to the CLSI standard (CLSI, 2013) 
from pure powder form, except for erythromycin, which was a liquid standard solution obtained from the manufacturer (45703 from Sigma). 
Tulathromycin was prepared according to the manufacturer’s recommendations (Pfizer). 
A total of 97 H. parasuis isolates collected between the years 2002 and 2013 were selected from the culture collection of the Microbiology 
Research Group. All isolates were diagnostic submissions from Australian pig herds. The isolates, which represent 28% of the total available 
culture collection of Australian field isolates, came from New South Wales (21 isolates), Queensland (36 isolates), South Australia (15 isolates), 
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Tasmania (1 isolate), Victoria (21 isolates) and Western Australia (3 isolates). The selection was made based on geographical and serovar 
diversity. All the isolates had been previously identified by species-specific polymerase chain reaction (Oliveira et al., 2001) and serotyped by 
either gel diffusion or indirect haemagglutination methods (Turni and Blackall, 2005). 
The antimicrobial susceptibility of the 97 H. parasuis isolates was detected by determination of the MIC in duplicate using TMB. The 
antimicrobials used were ampicillin, ceftiofur, florfenicol, erythromycin, penicillin, SXT, tetracycline, tilmicosin and tulathromycin. The MIC 
was defined as the lowest antimicrobial concentration that inhibited bacterial growth. 
3. Results and Discussion 
A standard antimicrobial susceptibility technique for H. parasuis does not currently exist. Other studies have used veterinary fastidious 
media (VFM) or Haemophilus test medium (Aarestrup et al., 2004; de la Fuente et al., 2007; Zhou et al., 2010) and involved incubation under 
5% CO2. In this study, we used two NAD enriched media under aerobic conditions - BA/SN and TMB (agar and broth) - for disc diffusion and 
MIC, respectively. Both media have been previously described and used in antimicrobial susceptibility testing of Avibacterium paragallinarum 
(Blackall, 1988) and H. parasuis (Lancashire, et al., 2005). In this study, all tested antimicrobials (ampicillin, ceftiofur, florfenicol, SXT and 
tetracycline for E. coli and ampicillin, ceftiofur, erythromycin, florfenicol, penicillin, SXT, tetracycline, tilmicosin and tulathromycin for S. 
aureus) showed results within the acceptable ranges across the antimicrobials for disc diffusion and broth microdilution (MIC) techniques in six 
independent repeats using the test media (BA/SN and TMB, respectively) (Table 1 and 2). The only exceptions were the disc diffusion test for 
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ceftiofur for E. coli, which showed smaller zones of inhibition on the third repeat for both media (BA/SN and Mueller Hinton agar), and the disc 
diffusion test for SXT for S. aureus (on BA/SN only) where zones of inhibition one to two millimetres smaller than the acceptable range (24-32 
mm) were recorded on five of the six repeats. The antimicrobial activity of trimethoprim and sulphonamide is influenced by the presence of 
antagonists (thymidine, thymine and folate) in the medium (CLSI, 2013). Some bacteria such as E. coli and S. aureus can utilise various amounts 
of exogenous thymidine and the effect of trimethoprim is correlated with the concentration of thymidine in the medium (Barry et al., 1984; 
Hamilton-Miller, 1988). In the current study, smaller zones of inhibition were observed around the SXT discs for S. aureus only (5/6 repeats) on 
the test medium. This agrees with the findings of Barry et al. (1984) who reported that S. aureus showed more sensitivity to trace amounts of 
antagonists than E. coli when testing for sulphonamide resistance. The trimethoprim and sulphonamide inhibitors have not been quantified in 
BA/SN, while Mueller-Hinton agar contains none of these inhibitors (CLSI, 2013). 
As noted above, in one rep at (1/6), an error in the disc diffusion of E. coli against ceftiofur on both test and standard media was detected. 
This error could be due to experimental factors which can be considered insignificant due to the single occurrence of the error (King and Brown, 
2001). 
Overall, this initial evaluation of methods using the proposed media suggests that BA/SN and TMB have the potential to be suitable media 
for the performance of antimicrobial susceptibility techniques of H. parasuis for disc diffusion and MIC, respectively. Further, more extensive 
evaluations are required on both media. 
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The MIC distribution of 97 H. parasuis isolates, the percentage of isolates with elevated antimicrobial MICs as well as the MIC50 and 
MIC90 are shown in Table 3. The MICs of the reference strains in each test run were within the CLSI acceptable quality control ranges. In the 
absence of agreed interpretation criteria, the MIC results were reviewed and a point that identified an elevated MIC was defined by the 
distribution of the MIC data – with those cut-off points being shown in Table 3. 
A percentage of isolates with elevated ampicillin (1%), penicillin (2%), erythromycin (7%), tulathromycin (9%), tilmicosin (22%), 
tetracycline (31%) and SXT (40%) MICs were detected (Table 3). Although, the prevalence of elevated MICs to antimicrobials found in the 
H. parasuis isolates included in this study is low, some isolates showed high MICs to tilmicosin (21/97) and tulathromycin (9/97), the newer 
macrolides. Additionally, five isolates showed high MICs to all macrolides used in this study, including tulathromycin. Tulathromycin resistance 
has recently been identified in H. parasuis isolates from the Czech Republic (Nedbalcová and Kucerova 2013). 
In summary, this study has identified potential antimicrobial susceptibility techniques for H. parasuis that might form the basis of a routine 
diagnostic technique to monitor antimicrobial susceptibility in this bacterial species following a full evaluation. Collaborative work on a full 
validation of these methods is now underway. This study also presented data on the occurrence of isolates of H. parasuis that show elevated 
MICs for key antimicrobial agents. National monitoring programs on antimicrobial susceptibility of important veterinary pathogens, using fully 
validated methodologies and agreed interpretation criteria, are necessary to allow veterinarians to prescribe the most rational treatment for 
bacterial infections. 
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Table 1. Antimicrobial disk susceptibility test zone diameters (mm) for reference strains Escherichia coli ATCC 25922 and Staphylococcus aureus 
ATCC 25923 using the standard media and the proposed media BA/SN in six independent repetitions.  
 QC Repeat 1 Repeat 2 Repeat 3 Repeat 4 Repeat 5 Repeat 6 
  ranges MH BA/SN MH BA/SN MH BA/SN MH BA/SN MH BA/SN MH BA/SN 
E. coli ATCC 25922             
Ampicillin 16- 22 19 17 17 17 18 16 19 17 18 17 19 18 
Ceftiofur 26- 31 27 26 27 27 23 24 27 26 26 26 28 28 
Florfenicol 22- 28 23 22 23 22 22 22 24 26 22 22 26 26 
SXT 23- 29 27 23 26 23 26 24 27 29 27 23 28 29 
Tetracycline 18- 25 25 24 25 24 24 23 23 22 24 24 25 24 
             
S. aureus ATCC 25923            
Ampicillin 27- 35 35 33 30 33 29 32 30 32 33 30 30 34 
Ceftiofur 27- 31 30 30 27 29 28 30 27 29 27 30 28 27 
Erythromycin 22- 30 24 25 23 23 23 23 24 24 23 25 26 26 
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Florfenicol 22- 29 22 29 22 25 23 24 22 24 24 23 24 26 
Penicillin 26- 37 31 36 37 35 34 34 30 34 33 36 33 37 
SXT 24- 32 30 24 28 22 26 22 27 22 29 22 30 23 
Tetracycline 24- 30 29 29 28 27 26 26 27 27 28 27 30 30 
Tilmicosin 17- 21 17 19 17 19 17 18 17 18 18 18 18 19 
Tulathromycin 18- 24 18 18 18 18 18 18 18 18 18 18 19 19 
Acceptable ranges are provided by Clinical and Laboratory Standards Institute (CLSI, 2013). 
MH- the standard media Mueller-Hinton agar. 
SXT- Trimethoprim and sulfamethoxazole combination 
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Table 2. Minimum inhibitory concentrations of antimicrobials (µg/ml) to reference strains Escherichia coli ATCC 25922 and Staphylococcus 
aureus ATCC 29213 using the standard media and the proposed media BA/SN in six independent repetitions.  
 QC Repeat 1 Repeat 2 Repeat 3 Repeat 4 Repeat 5 Repeat 6 
 ranges  MHB TMB MHB TMB MHB TMB MHB TMB MHB TMB MHB TMB 
E. coli ATCC 25922             
Ampicillin 2- 8 4 4 2 2 4 4 4 4 2 2 2 2 
Ceftiofur 0.25- 1 0.25 0.5 0.5 0.5 0.5 0.5 0.25 0.25 0.25 0.25 0.25 0.25 
Florfenicol 2- 8 4 4 4 4 8 8 8 8 4 4 4 4 
SXT 10 2.5 5 2.5 2.5 1.25 5 2.5 5 2.5 5 2.5 5 
Tetracycline 0.5- 2 1 1 1 1 0.5 0.5 0.5 0.5 2 1 2 2 
              
S. aureus ATCC 29213             
Ampicillin 0.5- 2 2 2 0.5 0.5 1 1 1 1 0.5 0.5 0.5 0.5 
Ceftiofur 0.25- 1 0.5 0.25 0.5 0.5 0.5 0.5 0.25 0.25 0.25 0.25 0.25 0.25 
Erythromycin 0.25- 1 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 
Florfenicol 2- 8 4 4 4 4 4 4 4 4 4 4 4 4 
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Penicillin 0.25- 1 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 
SXT 10 2.5 5 2.5 5 1.25 5 2.5 5 2.5 5 2.5 5 
Tetracycline 0.12- 1 0.25 0.25 0.25 0.25 0.125 0.125 0.25 0.25 0.5 0.25 0.25 0.25 
Tilmicosin 1.0- 4 1 1 1 1 1 1 1 1 1 1 1 1 
Tulathromycin 2.0- 8 2 4 2 2 4 4 4 4 4 4 4 4 
Acceptable ranges are provided by Clinical and Laboratory Standards Institute (CLSI, 2013). 
MHB- Mueller-Hinton broth 
SXT- Trimethoprim and sulfamethoxazole combination in a ratio of 1:19, the MIC of 10 is equivalent to 0.5/9.5 µg/ml. 
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Table 3. Minimum inhibitory concentration distribution of 97 Australian H. parasuis. 1 
Antimicrobial agents Number of isolates with MIC (µg/ml) of 
 0.12 0.25 0.5 1 2 4 8 16 32 
Ampicillin 69 11 9 6 1 1    
Ceftiofur 96 1         
Erythromycin  1 7 23 20 20 17 2 4 
Florfenicol 10 54 27 6      
Penicillin 56 22 10 6 1 2    
SXT 37 12 9 18 15 6    
Tetracycline 3 21 33 10 13 5 3 4 5 
Tilmicosin   11 29 19 10 7 9 5 
Tulathromycin 3 12 26 23 16 6 2 8   
MIC50, MIC90 - the lowest concentration of antimicrobial agent capable of inhibiting the growth of 50% and 
SXT- trimethoprim and sulfamethoxazole in the ratio 1:19; test ranges are expressed as the trimethoprim con
The isolates after the vertical lines were considered to have elevated antimicrobial MICs. 
 
 2 
3 
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Highlights 3 
The use of BA/SN for disk diffusion testing of Haemophilus parasuis was evaluated. 4 
Test medium broth (TMB) was evaluated for MIC tesing of H. parasuis. 5 
TMB was used in the antimicrobial susceptibility testing of H. parasuis. 6 
Low percentage of H. parasuis isolates with elevated antimicrobial MICs. 7 
 8 
